Target intelligence / Profile preview

GLI family zinc finger protein 1 (GLI1)

Target
GLI1
Molecular classification
Transcription factor, Zinc finger protein, Kruppel family protein
01

Overview

GLI family zinc finger protein 1 (GLI1) is a DNA-binding transcription factor in the Kruppel family of zinc finger proteins, which mediates the Hedgehog signaling pathway in vertebrates[1][3][4][6]. It regulates gene expression by binding to target gene promoters and functions as both a transcriptional activator and, under some contexts, a repressor[1]. GLI1 is essential for embryonic development—regulating cell fate, proliferation, and differentiation—and its dysregulation is implicated in oncogenesis, especially in tumors of the brain, skin (basal cell carcinoma), and muscle[1][3][6]. Aberrant activation of GLI1, through the Hedgehog pathway or gene amplification/mutation, drives tumorigenesis and is a key resistance mechanism to upstream pathway inhibitors[1]. GLI1 participates in gene regulatory networks through DNA-binding zinc finger domains and interacts with multiple cofactors (such as SUFU, STK36, SAP18, and ZIC1) to modulate chromatin architecture and gene expression[1][6]. Elevated GLI1 expression is both a functional marker of Hedgehog pathway activity and a prognostic indicator for some cancers[1]. GLI1 is one of three mammalian GLI proteins—with GLI2 and GLI3—each sharing structural motifs and mediating complementary or antagonistic roles within the Hedgehog (Shh) signaling axis[1][2].

Other names
Glioma-associated oncogeneOncogene GLIGLI-Kruppel family member GLI1glioma-associated oncogene 1glioma-associated oncogene homolog 1 (zinc finger)
02

Mechanism of action

Transcriptional regulation via direct DNA binding at GLI consensus sites Mediator of Sonic Hedgehog (Shh) signaling by acting as a transcriptional effector Interaction with cofactors (e.g., SUFU) modulates activation/repression functions

03

Biological functions

Cell fate determinationCell proliferationEmbryonic patterningTranscriptional regulation (activation and inhibition)Apoptosis regulationGene regulatory network integration
04

Disease associations

Cancer (notably glioblastoma, basal cell carcinoma, bone and soft tissue sarcomas, various tumors)TumorigenesisCongenital malformations (through pathway disruption)
05

Safety considerations

Oncogenic overexpressionPotential resistance to therapy via downstream alterations (e.g., mutations in or overexpression of GLI1 can circumvent SMO inhibitor blockade, leading to Hedgehog pathway-independent tumor growth)Normal developmental and tissue homeostasis roles raise concern for on-target toxicity
06

Interacting drugs

No clinically approved antagonists directly targeting GLI1, but small molecule inhibitors of the Hedgehog pathway (such as vismodegib, sonidegib) act upstream and affect GLI signaling indirectly by inhibiting Smoothened (SMO)[1].
07

Biomarkers

GLI1 expression as a biomarker for Hedgehog pathway activation in tumors (e.g., basal cell carcinoma, medulloblastoma)[1]GLI1 upregulation as a marker for prognosis in certain sarcomas and astrocytomas

Beyond the preview

Go deeper on GLI family zinc finger protein 1 (GLI1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GLI family zinc finger protein 1 (GLI1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call